Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.37 |
| ▸ | PDE2A | O00408 | 5/20 | 0.36 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.36 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL681325 | 0.91 | PDE2A (0.47) | PDE2ACACNA1HEPHX2GPR139 | |
| SCHEMBL681229 | 0.88 | CACNA1H (0.38) | KCNN4PDE2ASLC22A3CACNA1HADRB2 | |
| SCHEMBL681219 | 0.87 | AKT1 (0.40) | SLC22A3EPHX2 | |
| SCHEMBL12188490 | 0.87 | KCNN4 (0.38) | KCNN4PDE2ASLC22A3CACNA1HADRB2 | |
| SCHEMBL17803800 | 0.86 | SLC22A3 (0.47) | SLC22A3CACNA1HADRB2ADRB1ADRB3 | |
| SCHEMBL2739078 | 0.86 | KCNN4 (0.39) | KCNN4PDE2ASLC22A3CACNA1HADRB2 | |
| SCHEMBL680064 | 0.82 | PDPK1 (0.44) | ADRB2ADRB1ADRB3 | |
| SCHEMBL681710 | 0.81 | AKT1 (0.45) | ADRB2ADRB1ADRB3 | |
| SCHEMBL681686 | 0.81 | ALDH1A1 (0.43) | PDE2AADRB2ADRB1ADRB3EPHX2 | |
| SCHEMBL17803797 | 0.80 | ADRB2 (0.38) | ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8063050-B2 | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2011-11-22 | — | — | US | disclosed |